SCHEMBL14211423

SCHEMBL14211423

c1ccc(N(c2ccccc2)c2cc(-c3ccc(-c4c5ccccc5c(-c5c6ccccc6c(-c6ccc(-c7cc(N(c8ccccc8)c8ccccc8)cc(N(c8ccccc8)c8ccccc8)c7)cc6)c6ccccc56)c5ccccc45)cc3)cc(N(c3ccccc3)c3ccccc3)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ACHE P22303 4/20 0.35
ESR1 P03372 5/20 0.33
ESR2 Q92731 5/20 0.33
MEN1 O00255 1/20 0.32
CRHBP P24387 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
CRHR2 Q13324 1/20 0.32
TLR9 Q9NR96 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14211425 0.96 KDM4E (0.34) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL12774535 0.87 ALDH1A1 (0.35) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL12774538 0.87 ALDH1A1 (0.39) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL19953848 0.87 ALDH1A1 (0.42) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL14211426 0.86 ACHE (0.40) ALDH1A1L3MBTL1MAPTACHEMEN1
SCHEMBL13104655 0.86 ALDH1A1 (0.46) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL12774514 0.85 ALDH1A1 (0.36) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL2085941 0.85 ALDH1A1 (0.41) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL10063920 0.84 ALDH1A1 (0.46) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL10063937 0.84 ALDH1A1 (0.46) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120309974-A1 Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials BEIJING AGLAIA TECHNOLOGY DEVELOPMENT CO., LTD (CN) 2012-12-06 US disclosed
US-20120309974-A1 Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials BEIJING AGLAIA TECHNOLOGY DEVELOPMENT CO., LTD (CN) 2012-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309974-A1 Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials TYR, GALNT1, GALNT2 ALDH1A1 259/4885L3MBTL1 4152/4885KDM4E 2283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.